Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer research

Showing results (341-350 of 49,955) with videos related to

Pageof 4,996
Sort By:
Cancer Research|August 28, 2001
The mechanism of the growth-inhibitory effect of coxsackie and adenovirus receptor (CAR) on human bladder cancer: a functional analysis of car protein structureT Okegawa, R C Pong, Y Li, et al.
Cancer Research|June 18, 2002
Human cytomegalovirus infection and expression in human malignant gliomaCharles S Cobbs, Lualhati Harkins, Minu Samanta, et al.
Cancer Research|June 18, 2002
Influence of cytokine gene polymorphisms on the development of prostate cancerSarah L McCarron, Stephen Edwards, Philip R Evans, et al.
Cancer Research|June 18, 2002
Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomasShinichi Toyooka, Kiyomi O Toyooka, Kenichi Harada, et al.
Cancer Research|June 18, 2002
Prognostic significance of the metastasis-associated protein osteopontin in human breast cancerPhilip S Rudland, Angela Platt-Higgins, Mohamed El-Tanani, et al.
Cancer Research|June 18, 2002
Association of interferon regulatory factor-1, nucleophosmin, nuclear factor-kappaB, and cyclic AMP response element binding with acquired resistance to Faslodex (ICI 182,780)Zhiping Gu, Richard Y Lee, Todd C Skaar, et al.
Cancer Research|June 18, 2002
An E2F-responsive replication-selective adenovirus targeted to the defective cell cycle in cancer cells: potent antitumoral efficacy but no toxicity to normal cellKazunori Tsukuda, Rainer Wiewrodt, Katherine Molnar-Kimber, et al.
Cancer Research|June 18, 2002
Lack of promotion of estrogen-dependent mammary gland tumors in vivo by an isopropanolic Cimicifuga racemosa extractJohannes Freudenstein, Clemens Dasenbrock, Thomas Nisslein
Cancer Research|June 18, 2002
Anti-4-1BB monoclonal antibody enhances rejection of large tumor burden by promoting survival but not clonal expansion of tumor-specific CD8+ T cellsKenneth F May, Lieping Chen, Pan Zheng, et al.
Cancer Research|June 18, 2002
Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer familiesSiobhan S Wahlberg, James Schmeits, George Thomas, et al.
Pageof 4,996

Showing results (341-350 of 49,955) with videos related to

Sort By:
Pageof 4,996
Cancer Research|August 28, 2001
The mechanism of the growth-inhibitory effect of coxsackie and adenovirus receptor (CAR) on human bladder cancer: a functional analysis of car protein structureT Okegawa, R C Pong, Y Li, et al.
Cancer Research|June 18, 2002
Human cytomegalovirus infection and expression in human malignant gliomaCharles S Cobbs, Lualhati Harkins, Minu Samanta, et al.
Cancer Research|June 18, 2002
Influence of cytokine gene polymorphisms on the development of prostate cancerSarah L McCarron, Stephen Edwards, Philip R Evans, et al.
Cancer Research|June 18, 2002
Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomasShinichi Toyooka, Kiyomi O Toyooka, Kenichi Harada, et al.
Cancer Research|June 18, 2002
Prognostic significance of the metastasis-associated protein osteopontin in human breast cancerPhilip S Rudland, Angela Platt-Higgins, Mohamed El-Tanani, et al.
Cancer Research|June 18, 2002
Association of interferon regulatory factor-1, nucleophosmin, nuclear factor-kappaB, and cyclic AMP response element binding with acquired resistance to Faslodex (ICI 182,780)Zhiping Gu, Richard Y Lee, Todd C Skaar, et al.
Cancer Research|June 18, 2002
An E2F-responsive replication-selective adenovirus targeted to the defective cell cycle in cancer cells: potent antitumoral efficacy but no toxicity to normal cellKazunori Tsukuda, Rainer Wiewrodt, Katherine Molnar-Kimber, et al.
Cancer Research|June 18, 2002
Lack of promotion of estrogen-dependent mammary gland tumors in vivo by an isopropanolic Cimicifuga racemosa extractJohannes Freudenstein, Clemens Dasenbrock, Thomas Nisslein
Cancer Research|June 18, 2002
Anti-4-1BB monoclonal antibody enhances rejection of large tumor burden by promoting survival but not clonal expansion of tumor-specific CD8+ T cellsKenneth F May, Lieping Chen, Pan Zheng, et al.
Cancer Research|June 18, 2002
Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer familiesSiobhan S Wahlberg, James Schmeits, George Thomas, et al.
Pageof 4,996